NCT01759901 Effect of Vascular Inflow Occlusion in Open Liver Resection for Hepatocellular Carcinoma Status COMPLETED Phase NA
NCT01755767 Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy Status COMPLETED Phase PHASE3
NCT01752933 SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC) Status COMPLETED Phase PHASE2
NCT01733004 A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01721941 TH-302 Plus Doxorubicin Delivered by Trans-Arterial Chemoembolization (TACE) in Patients With Hepatocellular Carcinoma Status UNKNOWN Phase PHASE1
NCT01713244 Radiofrequency Ablation Assisted Hepatectomy Versus Hepatectomy Alone for Advanced Hepatocellular Carcinoma Status UNKNOWN Phase NA
NCT01710293 Intervention Protocol for Automated Point-of-Care Surveillance of Outpatient Delays in Cancer Diagnosis Status WITHDRAWN Phase NA
NCT01690715 Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery Status TERMINATED Phase N/A
NCT01687673 Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT01686880 Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver Status TERMINATED Phase PHASE2
NCT01686412 Determination of Autonomic Responses to Exposure to Electromagnetic Fields With Low Energy Modulated Frequency Status COMPLETED Phase NA
NCT01681446 Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression Status UNKNOWN Phase PHASE3
NCT01677468 Survival According to the Feeding Artery Obliteration by Chemoembolization for Unresectable Hepatocellular Carcinoma Status UNKNOWN Phase NA
NCT01676194 Transarterial Chemoembolization Prior to Transplantation for Hepatocellular Carcinoma Status TERMINATED Phase PHASE3
NCT01668381 Enumeration and Function Analysis of Treg Cells in Peripheral Blood of HCC Patients Before and After Ablation Therapy Status UNKNOWN Phase N/A
NCT01668017 A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Signal Regulated Kinase (MEK) Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as Monotherapy Status TERMINATED Phase PHASE1
NCT01658878 An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer Status COMPLETED Phase PHASE1/PHASE2